Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study have?
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study has 1,406 citations in the OpenAlex counts ScholarIQ stores.
When was Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study published?
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study has 2020 year in the ScholarIQ index.
What is the open-access status of Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study?
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study has gold oa status in the ScholarIQ index.
What is the DOI of Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study?
The DOI for Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study is on the source record.
What is the PMID of Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study?
The PMID for Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study is on the source record.
What is the OpenAlex record for Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study?
The OpenAlex for Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study is on the source record.